Pulmonary hypertension in sickle cell disease [6]

New England Journal of Medicine

Volumn 365, Issue 17, 2011, Pages 1646-1647

  Gladwin, Mark T ^a   Machado, Roberto F ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLOW UP; HEART CATHETERIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; LUNG ARTERY PRESSURE; MORTALITY; NATIONAL HEALTH ORGANIZATION; PATIENT CARE; PREVALENCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SCLERODERMA; SICKLE CELL ANEMIA; FEMALE; HEMODYNAMICS; MALE; NOTE;

ANEMIA, SICKLE CELL; FEMALE; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; MALE;

EID: 80054906327     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. Gladwin MT, Sachdev V, Jison ML, et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med 2004;350:886-95. (Pubitemid 38252536)
2. Anthi A, Machado RF, Jison ML, et al. Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension. Am J Respir Crit Care Med 2007;175: 1272-9. (Pubitemid 46905753)
3. Machado RF, Barst RJ, Yovetich NA, et al. Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity. Blood 2011;118:855-64.
4. Hachulla E, Gressin V, Guillevin L, et al. Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum 2005; 52:3792-800. (Pubitemid 41798217)